• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Pharmacokinetics of cefoperazone in healthy volunteers.

作者信息

Saudek F, Morávek J, Modr Z

出版信息

Czech Med. 1986;9(3):162-5.

PMID:3095076
Abstract

Pharmacokinetics of cefoperazone was studied in 10 healthy volunteers following 15 min intravenous infusion of 2 g. Cefoperazone levels in the blood serum and in the urine were determined microbiologically. At the end of the infusion, mean serum concentrations of the antibiotic were 340.4 (+/- 81.5) mg/l, at the 4th hour after the infusion 38.4 (+/- 10.3) mg/l, and 12 hours after the infusion all subjects had detectable concentrations with the mean value 2.2 (+/- 0.7) mg/l. Within 12 hours, 33.3 (+/- 6.1) % of the total dose of cefoperazone had been eliminated in the urine. The fitting of the individual serum concentration curves and the determination of pharmacokinetic constants were done according to a two-compartment model with the aid of nonlinear least-squares regression analysis on a programmable calculator TI 59. The mean value of the biological half-life (beta phase) of cefoperazone was 1.77 (+/- 0.25) h, mean serum clearance was 61.7 (+/- 12.1) ml/min and the mean distribution volume (Vd area) was 9.44 (+/- 2.2) 1. Our data are in agreement with those previously reported in the literature. The only exception is the distribution volume, which we found to be smaller.

摘要

相似文献

1
Pharmacokinetics of cefoperazone in healthy volunteers.
Czech Med. 1986;9(3):162-5.
2
Pharmacokinetics of cefoperazone after single and multiple doses.
Int J Clin Pharmacol Res. 1986;6(2):171-5.
3
[Serum concentration and kinetics after i.v.-infusion of 3 g lincomycin (author's transl)].
Arzneimittelforschung. 1979;29(1):130-4.
4
[Pharmacokinetic study of a cephalosporin, cefoperazone, in liver failure].
Schweiz Med Wochenschr. 1981 Apr 4;111(14):502-8.
5
[Pharmacokinetic study of a cephalosporin: cefoperazone in patients with a Kehr drain].[一种头孢菌素的药代动力学研究:用于有克尔引流管的患者的头孢哌酮]
Schweiz Med Wochenschr. 1982 Jan 23;112(4):123-9.
6
Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.在两项针对健康志愿者的研究以及两项针对慢性肾病患者的研究中,δ-促红细胞生成素的药代动力学和药效学。
Clin Ther. 2007 Jul;29(7):1368-80. doi: 10.1016/j.clinthera.2007.07.014.
7
Pharmacokinetics and pharmacodynamics of aztreonam administered by continuous intravenous infusion.持续静脉输注氨曲南的药代动力学和药效学
Clin Ther. 1999 Nov;21(11):1882-9. doi: 10.1016/S0149-2918(00)86736-3.
8
Pharmacokinetics of azlocillin in healthy subjects.阿洛西林在健康受试者中的药代动力学。
Scand J Infect Dis Suppl. 1981;29:49-54.
9
Cefoperazone pharmacokinetics in patients with liver cirrhosis: a predictive value of the ujoviridin test.
Int J Clin Pharmacol Ther Toxicol. 1989 Feb;27(2):82-7.
10
Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol.曲马多的药代动力学及肠内曲马多制剂的生物利用度。第二次通讯:含乙醇滴剂
Arzneimittelforschung. 1998 May;48(5):436-45.